drugset / Trial / NCT06462417

Efficacy and Safety of Arbidol in the Treatment of Allergic Rhinitis

NCT06462417

NaSingle-groupOpen-labelTreatment

Summary

The most important treatment for AR is topical nasal medications (including nasal corticosteroids, nasal antihistamines, nasal decongestants, and nasal saline irrigation etc.), which are still limited. Arbidol may inhibit molecular targets involved in the pathogenesis of AR. This study intends to explore the effect of Arbidol in the treatment of allergic rhinitis and evaluate its efficacy and safety.

Timeline

Start
2024-07-11
Primary completion
2025-06-30
Completion
2025-06-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Umifenovir Small molecule 0.2 g Oral

Indications